Literature DB >> 21586965

Pleomorphic adenomas recurrences within the parapharyngeal space.

Şenol Polat1, Gediz Murat Serin, Ozmen Öztürk, Cüneyd Üneri.   

Abstract

This study was undertaken to evaluate and concentrate on the recurrent pleomorphic adenomas (PAs) of the parapharyngeal space. The records of 9 patients treated for recurrent PAs occupying parapharyngeal space were retrospectively reviewed. The study population comprised 6 women and 3 men with a mean age of 51 (range, 35-79 years). Before the first revision surgery, imaging studies and clinical examinations showed 1 solitary mass in 4 patients, 2 solitary masses in 3 patients, and 3 or more masses in 2 patients. After first revision surgery, 4 patients had rerecurrences with multinodular disease. Two of 4 patients underwent radiation therapy (RT), and the other 2 patients underwent second revision surgery, among whom 1 patient underwent third revision surgery, and the other one was also submitted to RT. Overall, 12 reoperations were performed, and at the end of all operations, 4 patients had rerecurrences and residual disease. In conclusion, we recommend RT to patients with multinodular disease, known tumor spillage, and residual tumor in addition to revision surgery. Histopathologic features, surgical resection, relationship to surrounding vital tissues, and postoperative adjuvant radiotherapy are the most important determinants for recurrent PAs.

Entities:  

Mesh:

Year:  2011        PMID: 21586965     DOI: 10.1097/SCS.0b013e3182108f3b

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  2 in total

1.  Transoral robotic surgery for the parapharyngeal space: expanding the transoral corridor.

Authors:  Smriti Panda; Kapil Sikka; Alok Thakar; Suresh C Sharma; Padmavathi Krishnamurthy
Journal:  J Robot Surg       Date:  2019-02-14

2.  Parotid tail pleomorphic adenoma extending to the parapharyngeal space.

Authors:  Kerem Polat; Mansur Doğan; Salim Yüce; Ismail Önder Uysal; Suphi Müderris
Journal:  J Craniofac Surg       Date:  2013-03       Impact factor: 1.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.